Bolt Biotherapeutics, Inc. Common Stock BOLT
$4.95
+7.84%
at last close
Financials (TTM)
- Revenue
- $6.50 million
- Net Income
- $-29,580,000
- Net Margin
- -455.15%
- Return on Equity
- -149.23%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.48
- Price / Sales
- 1.46
Over the trailing twelve months, Bolt Biotherapeutics, Inc. Common Stock generated revenue of $6.50 million and net income of $-29,580,000, a net margin of -455.15%.
At the last closing price of $4.95, BOLT trades at 1.46 times sales, with a market capitalization of $9.51 million.
Key Stats
- Last Close
- $4.95
- Market Cap
- $9.51 million
- 52-Week Range
- $3.91 – $9.25
- Average Volume
- 30K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.